ClearBridge LLC (Maryland)’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
ClearBridge LLC (Maryland)'s BMY Position: Q4 2018 in Review
ClearBridge LLC (Maryland) reduced its Bristol-Myers Squibb (BMY) stake by 0.67% in Q4 2018, selling an estimated $27.7K and leaving 76,366 shares worth $3.97M. The position accounts for 1.21% of the portfolio, ranked #36.
ClearBridge LLC (Maryland) first reported a position in BMY in Q2 2014 and has held it in 17 quarters since. The position peaked at $108M in Q3 2016. 1,765 funds tracked by Wall St. Rank hold BMY as of Q4 2018.
- ClearBridge LLC (Maryland) held 76,366 shares of Bristol-Myers Squibb worth $3.97M as of Q4 2018.
- ClearBridge LLC (Maryland) sold 515 Bristol-Myers Squibb shares in Q4 2018, an estimated $27.7K.
- Bristol-Myers Squibb made up 1.21% of ClearBridge LLC (Maryland)'s portfolio in Q4 2018, its #36 holding.
- ClearBridge LLC (Maryland) first reported a position in Bristol-Myers Squibb in Q2 2014 and has held it in 17 quarters since.
- ClearBridge LLC (Maryland)'s Bristol-Myers Squibb position peaked at $108M in Q3 2016.
- 1,765 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2018.
Based on ClearBridge LLC (Maryland)'s 13F filing for Q4 2018, filed 14 Feb 2019.